EuCanImage: Next-generation artificial intelligence in oncology

Reserachers of Hospital Clínic-IDIBAPS participate in EuCanImage, a project from the Horizon 2020 program that will build a federated and scalable cancer imaging platform, to contribute to the improvement of the potential of artificial intelligence and precision medicine in oncology.

This project is coordinated by Karim Lekadir, Ramón y Cajal postdoctoral researcher at the Faculty of Mathematics and Computer Science, and is funded by the European Commission with ten million euros.

This four-year research project will comprise twenty world-renowned research institutions, companies and clinical centers across Europe and the United States. The Spanish institutions that participate in the project include the University of Barcelona but also the Hospital Clínic de Barcelona, the Barcelona Supercomputing Center, the Centre for Genomic Regulation and the University of the Basque Country.

The EuCanImage platform will have a new data resource totaling over 25,000 subjects, which will allow to investigate unmet clinical needs like never before, such as for the detection of small liver lesions and metastases of colorectal cancer, and it will also allow to estimate molecular subtypes of breast tumors and will develop AI solutions to estimate a complete  pathological  response.

Moreover, the cancer imaging platform, leveraging the well-established EuroBioImaging infrastructure, will be cross-linked to biological and health repositories through the European Genome-phenome Archive, allowing to develop multi-scale AI solutions that integrate organ-level, molecular and other clinical predictors into dense patient-specific cancer fingerprints.

“EuCanImage is an unprecedented opportunity to create a long-awaited European platform for sharing and leveraging large-scale cancer imaging and non-imaging data. It will leverage world-renown expertise in the fields of radiomics/radiogenomics, artificial intelligence, data protection, data management, and clinical oncology” notes Karim Lekadir.

The project, which started on October 1, will hold its kick-off meeting on October 13 and 14.

The following partners take part in the EuCanImage consortium:

  • University of Barcelona (project coordinator)
  • Universiteit Maastricht (the Netherlands)
  • Erasmus Medical Center Rotterdam, Euro-BioImaging Node, (the Netherlands)
  • Barcelona Supercomputing Center (Spain)
  • Centre for Genomic Regulation (Spain)
  • University of Arkansas for Medical Sciences / The Cancer Imaging Archive (United States)
  • Biobanking and Biomolecular Resources Research Infrastructure (Austria)
  • University of the Basque Country (Spain)
  • Lynkeus Srl (Italy)
  • Collective Minds Radiology AB (Sweden)
  • OncoRadiomics SA (Belgium)
  • Siemens Healthcare GmbH (Germany)
  • European Institute for Biomedical Imaging Research (Austria)
  • European Society of Oncologic Imaging (Austria)
  • European Association for Cancer Research (United Kingdom)
  • University of Pisa (Italy)
  • Fundació Clínic Recerca Biomèdica / Hospital Clínic de Barcelona (Spain)
  • Umeå Universitet (Sweden)
  • Gdański Uniwersytet Medyczny (Poland)
  • Kauno Klinikos (Lithuania)